Frank Takkinen
Stock Analyst at Lake Street
(0.73)
# 3,844
Out of 4,876 analysts
59
Total ratings
23.21%
Success rate
-21.63%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Assumes: Buy | $30 | $14.99 | +100.13% | 1 | Jun 12, 2025 | |
| ELUT Elutia | Maintains: Buy | $10 → $8 | $1.85 | +332.43% | 3 | May 9, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $2.5 → $3 | $4.25 | -29.41% | 4 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.84 | +171.74% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $5.87 | +138.50% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.60 | +19.05% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.73 | +105.14% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $10.47 | +186.53% | 1 | Mar 17, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $16.31 | +59.41% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $12.02 | +149.58% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $3.58 | +39.66% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.00 | +400.00% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.26 | +121.24% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.85 | +332.43% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $30.62 | -2.02% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.59 | +363.32% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.48 | +305.41% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.21 | +81.00% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $10.94 | +9.69% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $129.71 | +169.83% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $3.86 | +29.53% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.18 | +312.84% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.74 | +822.19% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.62 | +1,393.77% | 2 | Jan 18, 2023 |
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $14.99
Upside: +100.13%
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $1.85
Upside: +332.43%
Sight Sciences
May 9, 2025
Maintains: Hold
Price Target: $2.5 → $3
Current: $4.25
Upside: -29.41%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.84
Upside: +171.74%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $5.87
Upside: +138.50%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.60
Upside: +19.05%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.73
Upside: +105.14%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $10.47
Upside: +186.53%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.31
Upside: +59.41%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $12.02
Upside: +149.58%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.58
Upside: +39.66%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.00
Upside: +400.00%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.26
Upside: +121.24%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.85
Upside: +332.43%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $30.62
Upside: -2.02%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $2.59
Upside: +363.32%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.48
Upside: +305.41%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.21
Upside: +81.00%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $10.94
Upside: +9.69%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $129.71
Upside: +169.83%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $3.86
Upside: +29.53%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.18
Upside: +312.84%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.74
Upside: +822.19%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.62
Upside: +1,393.77%